FDA issued a Warning Letter to Pharmalucence, Inc. on 9/23/2008 for a previous inspection.
483 Pharmalucence Jun 2016

483 Pharmalucence Jun 2016

Erik Koester FDA, Robert Martin FDA$119.00 - Available Now

FDA investigators audited the Pharmalucence - Bedford, MA, United States facility and issued inspectional observations (via FDA 483) on 29 Jun 2016.

Product details

  • Category: Human Drugs
  • Inspection end: 29 Jun 2016
  • Location: Bedford, United States
  • FEI: 1219718
Add To Cart